Exchange: NASDAQ·Updated 07:53 PM EST

CTXR News

News
all
press releases
Citius Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in London
Citius Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in London Citius Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in LondonPR NewswireCRANFORD, N.J., Nov. 11, 2026 Chairman and CEO Leonard Mazur to host one-on-one business development...
PR Newswire
Citius Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in London
Citius Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in London Citius Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in LondonPR NewswireCRANFORD, N.J., Nov. 11, 2026 Chairman and CEO Leonard Mazur to host one-on-one business development...
PR Newswire
More News
Citius Oncology's Positive Quality of Life Data for LYMPHIR (denileukin diftitox-cxdl) in Relapsed or Refractory Cutaneous T-Cell Lymphoma Presented at Premier Global CLTG Congress in Europe Citius Oncology's Positive Quality of Life Data for LYMPHIR (denileukin diftitox-cxdl) in Relapsed or...
PR Newswire
Citius Oncology Reports Continued Institutional Demand and 120% Growth in Shipments of LYMPHIR Units to U.S. Wholesalers During the Fiscal Fourth Quarter of 2026 Citius Oncology Reports Continued Institutional Demand and 120% Growth in Shipments of LYMPHIR Units to U.S. Wholesalers During the...
PR Newswire
Citius Pharmaceuticals to Participate in October 2026 Investor Conferences Citius Pharmaceuticals to Participate in October 2026 Investor ConferencesPR NewswireCRANFORD, N.J., Oct. 12, 2026Chairman and CEO Leonard Mazur to present and host one-on-one investor meetings at the 2026 Maxim Growth...
PR Newswire
Citius Pharmaceuticals to Participate in September 2026 Investor Conferences Citius Pharmaceuticals to Participate in September 2026 Investor Conferences PR Newswire CRANFORD, N.J., Sept. 3, 2026 Chairman and CEO Leonard Mazur to present and host one-on-one investor meetings at the H.C. Wainwright...
PR Newswire
Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update PR Newswire CRANFORD, N.J., Aug. 14, 2026 $7.1 Million in revenue for the first...
PR Newswire
Citius Oncology, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update Citius Oncology, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update PR Newswire CRANFORD, N.J., Aug. 14, 2026 $7.1 million in revenue for the first nine months...
PR Newswire
Citius Oncology Expands Board with Appointment of Independent Director Jonathan Peri Citius Oncology Expands Board with Appointment of Independent Director Jonathan Peri PR Newswire CRANFORD, N.J., Aug. 12, 2026 CRANFORD, N.J., Aug. 12, 2026 /PRNewswire/ -- Citius Oncology, Inc. ("Citius Oncology...
PR Newswire
Citius Oncology Reports Strong Commercial Momentum for its Cancer Treatment Citius Oncology Reports Strong Commercial Momentum for its Cancer Treatment PR Newswire CRANFORD, N.J., Aug. 5, 2026 New institutional accounts ordering LYMPHIR increased 78% quarter over quarterLYMPHIR's near-universal...
PR Newswire
Citius Oncology Reports Nationwide Deployment of LYMPHIR's Broadened Commercial Organization and Expanding Market Adoption Citius Oncology Reports Nationwide Deployment of LYMPHIR's Broadened Commercial Organization and Expanding Market Adoption PR Newswire CRANFORD, N.J., July 21, 2026 Expanded...
PR Newswire

Advertisement|Remove ads.